About Kanjinti

Kanjinti (trastuzumab-anns) is used to treat stomach and breast cancer. Kanjinti is a biosimilar for herceptin (trastuzumab). Biosimilars are biologic drugs that are similar to the original medication with no meaningful differences in effectiveness or safety. Kanjinti may be covered by your Medicare or insurance plan. With the Patient Assistance Program from Genentech, you can receive your medication at no cost.

Herceptin is a healthcare provider (HCP) administered specialty medication.
HCP administered medications are sold and given to you by your physician. The doctor’s office will process any payments related to your visit and treatment.
GoodRx coupons are not available at HCP offices for these medications, but there might be other ways you can save on your prescription.